PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: bankruptcy

Type 2 Diabetes Screening and Treatment Guideline

1996 Kaiser Foundation Health Plan of Washington. All rights Type 2 Diabetes Screening and Treatment Guideline Major Changes as of April 2019 .. 2 Prevention .. 2 Screening and Tests .. 2 3 Treatment .. 4 Risk-reduction goals .. 4 Lifestyle modifications and non-pharmacologic options .. 4 Bariatric surgery .. 6 Pharmacologic options for glucose control .. 6 Type 2 Diabetes Treatment workflow for Primary Care .. 9 Type 2 Diabetes Treatment : when to consider glargine or U-500 insulin ..10 Additional pharmacologic options to consider in consultation with Diabetes Team ..11 Pharmacologic options that are not recommended ..12 Referral to Nursing or Clinical Pharmacy ..13 Follow-up and Monitoring ..14 Self blood glucose monitoring ..14 Periodic monitoring of conditions and complications ..15 Medication monitoring ..15 Recommended immunizations ..16 Comorbidities ..16 Evidence Summary ..17 References ..21 Guideline Development Process and Team ..23 Last Guideline approval: April 2019 Guidelines are systematically developed statements to assist patients and providers in choosing appropriate health care for specific clinical conditions.

It is now recommended that diabetes screening for patients with overweight/obesity start at age 35, to be in alignment with new 2021 U.S. Preventive Services Task Force recommendations. Previously, screening was recommended for such patients starting at age 45.

Tags:

  Screening, Diabetes, Overweight, Diabetes screening

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Type 2 Diabetes Screening and Treatment Guideline

Related search queries